Emil D. Kakkis, President & CEO: Ultragenyx Pharmaceutical RARE Sell · Filed 23/01/03

Trade details

Type: Insider sale
Amount: $892,351.74
Shares · price: 19,582 sh · $45.57 a share
Held after: 541,108 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Emil D. KakkisPresident & CEO
Trade date: 22/12/30
Filed: 23/01/03
Days to filing: 4 days

Sold 3.5% of holdings

Share of holding sold: 3.5%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 22/11/30~23/01/29

Emil D. Kakkis's recent trades

Emil D. KakkisPresident & CEO
SellUltragenyx Pharmaceutical
Sell
Ultragenyx Pharmaceutical
RARE
$1.2M
54,404 sh
$1.2M
Filed 03/03
Traded 03/02
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$3.1M
73,434 sh
$3.1M
Filed 25/03/04
Traded 25/03/03
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/03/04
Traded 25/02/28
Emil D. KakkisOfficer
Planned sale10b5-1 planUltragenyx Pharmaceutical
Planned sale10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/02/28
Traded 25/02/28
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$495.2K
11,727 sh
$495.2K
Filed 24/12/31
Traded 24/12/30

Emil D. Kakkis, CEO — sold $892.4K of Ultragenyx Pharmaceutical RARE · 3.5% of holdings | Whalegun